A Phase 1, 2-Part Study to Evaluate the Pharmacokinetics of Trilaciclib in Hepatic Impairment Subjects and in Matching Healthy and in Matching Healthy Control Subjects

Principal Investigator

Richard Preston

Enrollment Status

Closed

Clinical Trial ID

Institutional Protocol # 20191289

Clinical Trial Summary

A Phase 1, 2-Part Study to Evaluate the Pharmacokinetics of Trilaciclib in Hepatic Impairment Subjects and in Matching Healthy Control Subjects
Sponsor Project No.: G1T28-113

Phase

Phase I

Funding Agency/Sponsor

Intramural

Disease

Other

Contact Information

Study Contact Olga Acosta

Phone Number +1 (305) 9844319

Email oacosta@miami.edu